Profile
Dr. Dian Wang graduated from the Ohio State University Medical Center, specializing in Radiation Oncology. He currently serves as the Clinical Director of the Radiation Oncology Center at Oak Park Hospital in the US. Concurrently, he holds the positions of Professor in the Department of Radiation Oncology at Rush University Medical Center, Co-Executive Director of the Genitourinary Oncology Program, and Director of the Brachytherapy Center.
His long-term clinical research focuses on radiation oncology, primarily specializing in the radiotherapy of prostate cancer, sarcoma, and head and neck cancers. He has extensive expertise in precision techniques such as Image-Guided, High-Dose Intensity-Modulated Radiation Therapy (IMRT), particle implantation (Brachytherapy), and Stereotactic Body Radiotherapy (SBRT). As Chair of the Sarcoma Committee for the Radiation Therapy Oncology Group (RTOG), he leads multiple national clinical research initiatives and has presented cutting-edge findings at international academic conferences, including ASCO. He also serves as Editor-in-Chief of the journal Rare Tumors and as a board member of the Sino-American Radiation Therapy Association (SANTRO), promoting international exchange in oncology diagnosis and treatment technologies. His leadership in studies, such as RTOG 0630, has provided crucial clinical evidence for optimizing radiotherapy protocols for prostate cancer.
